Advances in HR+/HER2- Metastatic Breast Cancer: Current Practice, Open Questions, and Future Directions

Download slidesets from our satellite symposium at SABCS 2018 where expert faculty shared their perspectives on the evolving treatment paradigm in HR+/HER2- MBC, including the subtleties of optimal clinical application of CDK4/6 inhibitor therapy, the latest clinical data on PI3K pathway blockade, and how new strategies may affect management of these patients in the near future.

Matthew P. Goetz, MD
Sara Hurvitz, MD, FACP
Joyce O'Shaughnessy, MD

Downloadable Slidesets

Download this slideset to review the latest clinical data informing optimal use of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer.

Joyce O'Shaughnessy, MD Released: December 5, 2018

Download this slideset to review the latest clinical data on the evolving role of mTOR and PIK3 inhibitors in the treatment of HR+/HER2- metastatic breast cancer.

Sara Hurvitz, MD, FACP Released: December 5, 2018

Download this slideset to explore future directions in the treatment of HR+/HER2- metastatic breast cancer, including progression after CDK4/6i and a role for HDAC inhjbitors.

Matthew P. Goetz, MD Released: December 5, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

This activity is supported by educational grants from
Novartis Pharmaceuticals Corporation
Syndax

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?